Kingsview Wealth Management’s Innovator US Equity 10 Buffer ETF Quarterly ZALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.19M Buy
36,604
+915
+3% +$29.9K 0.02% 621
2025
Q4
$1.16M Buy
35,689
+3,703
+12% +$119K 0.02% 596
2025
Q3
$1.02M Buy
31,986
+2,212
+7% +$69.5K 0.02% 606
2025
Q2
$917K Buy
29,774
+9,849
+49% +$296K 0.02% 607
2025
Q1
$593K Buy
19,925
+1,882
+10% +$56.5K 0.01% 676
2024
Q4
$537K Buy
18,043
+4,602
+34% +$137K 0.01% 713
2024
Q3
$393K Buy
13,441
+2,672
+25% +$76.5K 0.01% 790
2024
Q2
$305K Sell
10,769
-5
-0% -$138 0.01% 829
2024
Q1
$295K Buy
+10,774
New +$291K 0.01% 817

Other funds holding ZALT

Kingsview Wealth Management's ZALT Position: Q1 2026 in Review

Kingsview Wealth Management increased its Innovator US Equity 10 Buffer ETF Quarterly (ZALT) stake by 2.6% in Q1 2026, buying an estimated $29.9K and bringing the position to 36,604 shares worth $1.19M. The position accounts for 0.02% of the portfolio, ranked #621.

Kingsview Wealth Management first reported a position in ZALT in Q1 2024 and has held it in 9 quarters since. 103 funds tracked by Wall St. Rank hold ZALT as of Q1 2026.

  • Kingsview Wealth Management held 36,604 shares of Innovator US Equity 10 Buffer ETF Quarterly worth $1.19M as of Q1 2026.
  • Kingsview Wealth Management bought 915 Innovator US Equity 10 Buffer ETF Quarterly shares in Q1 2026, an estimated $29.9K.
  • Innovator US Equity 10 Buffer ETF Quarterly made up 0.02% of Kingsview Wealth Management's portfolio in Q1 2026, its #621 holding.
  • Kingsview Wealth Management first reported a position in Innovator US Equity 10 Buffer ETF Quarterly in Q1 2024 and has held it in 9 quarters since.
  • 103 funds tracked by Wall St. Rank held Innovator US Equity 10 Buffer ETF Quarterly as of Q1 2026.

Based on Kingsview Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.